<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00707226</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-171000</org_study_id>
    <nct_id>NCT00707226</nct_id>
  </id_info>
  <brief_title>Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes</brief_title>
  <official_title>Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      After focusing many years only on intraocular pressure (IOP) as the primary risk factor,&#xD;
      recently the impact of ocular blood flow is getting more consideration for the&#xD;
      pathophysiology of glaucoma. The circadian change of intraocular pressure (IOP) is well&#xD;
      investigated, but diurnal variations in ocular blood flow are yet to be evaluated, especially&#xD;
      in glaucomatous eyes.&#xD;
&#xD;
      This study is performed to investigate circadian variation of ocular blood flow assessed by&#xD;
      laser interferometric fundus pulsation amplitude (FPA) and laser Doppler flowmetry (LDF) in&#xD;
      glaucomatous eyes during topical antiglaucoma therapy at 8:00, 12:00, 17:00 and 21:00, to&#xD;
      compare these circadian variation of ocular blood flow in glaucomatous eyes with variations&#xD;
      in healthy eyes and to relate blood flow variations with IOP variations.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2000</start_date>
  <completion_date type="Actual">December 2001</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fundus pulsation amplitude choroidal blood flow IOP</measure>
    <time_frame>13 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure, pulse rate</measure>
    <time_frame>13 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Glaucoma, Open-Angle</condition>
  <condition>Circadian Rhythm</condition>
  <condition>Intraocular Pressure</condition>
  <condition>Regional Blood Flow</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>15 patients with primary open angle glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>15 age matched healthy subjects</description>
  </arm_group>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        For the glaucoma patients:&#xD;
&#xD;
          -  Medical controlled Primary Open Angle Glaucoma with a history of more than 2 years&#xD;
&#xD;
          -  Topical medication with beta-blockers (timolol, betaxolol, levobunol)&#xD;
&#xD;
          -  IOP with medication &lt; 22 mmHg (with a medical history of IOP &gt; 22 mmHg)&#xD;
&#xD;
          -  Visual field testing: mild glaucomatous defects (Humphrey 30-2 with MD&gt;10)&#xD;
&#xD;
          -  Optic nerve head: C/D-ratio between 0.4 and 0.9&#xD;
&#xD;
          -  ametropy &lt; 3 dpt&#xD;
&#xD;
          -  Normal findings in the medical history and physical examination unless the&#xD;
             investigator considers an abnormality to be clinically irrelevant&#xD;
&#xD;
        For the age matched control subjects:&#xD;
&#xD;
          -  Normal findings in the medical history and physical examination unless the&#xD;
             investigator considers an abnormality to be clinically irrelevant&#xD;
&#xD;
          -  Normal laboratory values unless the investigator considers an abnormality to be&#xD;
             clinically irrelevant&#xD;
&#xD;
          -  Normal ophthalmic findings, ametropy &lt; 3 dpt.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For the glaucoma patients:&#xD;
&#xD;
          -  History of trabeculectomy or laser trabeculoplasty&#xD;
&#xD;
          -  Any other ocular disease with possible vascular involvement such as diabetic&#xD;
             retinopathy, age related macular disease, retinal vein or artery occlusion.&#xD;
&#xD;
          -  Uncontrolled systemic hypertension (defined as systolic blood pressure &gt; 170 mmHg or&#xD;
             diastolic blood pressure &gt; 100 mmHg)&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
        For the age matched control subjects:&#xD;
&#xD;
          -  abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks&#xD;
             preceding the study&#xD;
&#xD;
          -  Symptoms of a clinically relevant illness in the 3 weeks before the first study day&#xD;
&#xD;
          -  History or presence of gastrointestinal, liver or kidney disease&#xD;
&#xD;
          -  Ametropy &gt; 3 dpt&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Georgopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Ophthalmology, Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Clinical Pharmacology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <study_first_submitted>June 26, 2008</study_first_submitted>
  <study_first_submitted_qc>June 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2008</study_first_posted>
  <last_update_submitted>June 27, 2008</last_update_submitted>
  <last_update_submitted_qc>June 27, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2008</last_update_posted>
  <responsible_party>
    <name_title>Michael Georgopoulos</name_title>
    <organization>Medical University of Vienna</organization>
  </responsible_party>
  <keyword>Laser Doppler flowmetry</keyword>
  <keyword>Choroidal blood flow</keyword>
  <keyword>Fundus pulsation amplitude</keyword>
  <keyword>Intraocular Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

